Outpatient Medicine - Cancer

Front 1

The U.S. Preventive Services Task Force (USPSTF) ________ routine use of tamoxifen or raloxifene for the primary prevention of breast cancer in women at low or average risk for breast cancer.

Back 1

The U.S. Preventive Services Task Force (USPSTF) RECOMMEDNS AGAINST routine use of tamoxifen or raloxifene for the primary prevention of breast cancer in women at low or average risk for breast cancer. (D)

Front 2

The USPSTF ________ clinicians discuss chemoprevention with women at high risk for breast cancer and at low risk for adverse effects of chemoprevention.

Back 2

The USPSTF RECOMMENDS that clinicians discuss chemoprevention with women at high risk for breast cancer and at low risk for adverse effects of chemoprevention. (B)

Front 3

The USPSTF _________ the routine use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent colorectal cancer in individuals at average risk for colorectal cancer.

Back 3

The USPSTF recommends against the routine use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent colorectal cancer in individuals at average risk for colorectal cancer. (D)

Front 4

The U.S. Preventive Services Task Force (USPSTF) ________ routine screening for bladder cancer in adults

Back 4

The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for bladder cancer in adults. (D)

Front 5

The U.S. Preventive Services Task Force (USPSTF) _______ routine referral for genetic counseling or routine breast cancer susceptibility gene (BRCA) testing for women whose family history is not associated with an increased risk for deleterious mutations in breast cancer susceptibility gene 1 (BRCA1) or breast cancer susceptibility gene 2 (BRCA2).

Back 5

The U.S. Preventive Services Task Force (USPSTF) recommends against routine referral for genetic counseling or routine breast cancer susceptibility gene (BRCA) testing for women whose family history is not associated with an increased risk for deleterious mutations in breast cancer susceptibility gene 1 (BRCA1) or breast cancer susceptibility gene 2 (BRCA2). (D)

Front 6

The USPSTF __________ women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 genes be referred for genetic counseling and evaluation for BRCA testing.

Back 6

The USPSTF recommends that women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 genes be referred for genetic counseling and evaluation for BRCA testing. (B)

Front 7

The U.S. Preventive Services Task Force (USPSTF) ___________ screening mammography, with or without clinical breast examination (CBE), every 1-2 years for women aged 40 and older.

Back 7

The U.S. Preventive Services Task Force (USPSTF) recommends screening mammography, with or without clinical breast examination (CBE), every 1-2 years for women aged 40 and older. (B)

Front 8

The USPSTF _________ routine CBE alone to screen for breast cancer.

Back 8

The USPSTF concludes that the evidence is insufficient to recommend for or against routine CBE alone to screen for breast cancer.

Front 9

The USPSTF _________ teaching or performing routine breast self-examination (BSE).

Back 9

The USPSTF concludes that the evidence is insufficient to recommend for or against teaching or performing routine breast self-examination (BSE).

Front 10

The USPSTF ______ screening for cervical cancer in women who have been sexually active and have a cervix.

Back 10

The USPSTF strongly recommends screening for cervical cancer in women who have been sexually active and have a cervix. (A)

Front 11

The USPSTF _________ routinely screening women older than age 65 for cervical cancer if they have had adequate recent screening with normal Pap smears and are not otherwise at high risk for cervical cancer

Back 11

The USPSTF recommends against routinely screening women older than age 65 for cervical cancer if they have had adequate recent screening with normal Pap smears and are not otherwise at high risk for cervical cancer. (D)

Front 12

The USPSTF ________ routine Pap smear screening in women who have had a total hysterectomy for benign disease.

Back 12

The USPSTF recommends against routine Pap smear screening in women who have had a total hysterectomy for benign disease. (D)

Front 13

The USPSTF ______ the routine use of new technologies (i.e. liquid cytology) to screen for cervical cancer.

Back 13

The USPSTF concludes that the evidence is insufficient to recommend for or against the routine use of new technologies to screen for cervical cancer.

Front 14

The USPSTF _________ the routine use of human papillomavirus (HPV) testing as a primary screening test for cervical cancer.

Back 14

The USPSTF concludes that the evidence is insufficient to recommend for or against the routine use of human papillomavirus (HPV) testing as a primary screening test for cervical cancer.

Front 15

The USPSTF ________ that clinicians screen men and women 50 years of age or older for colorectal cancer.

Back 15

The USPSTF strongly recommends that clinicians screen men and women 50 years of age or older for colorectal cancer. (A)

Front 16

The U.S. Preventive Services Task Force (USPSTF) _________ screening asymptomatic persons for lung cancer with either low dose computerized tomography (LDCT), chest x-ray (CXR), sputum cytology, or a combination of these tests.

Back 16

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend for or against screening asymptomatic persons for lung cancer with either low dose computerized tomography (LDCT), chest x-ray (CXR), sputum cytology, or a combination of these tests.

Front 17

The U.S. Preventive Services Task Force (USPSTF) _________ routinely screening adults for oral cancer.

Back 17

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend for or against routinely screening adults for oral cancer.

Front 18

The U.S. Preventive Services Task Force (USPSTF) _______ routine screening for ovarian cancer.

Back 18

The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for ovarian cancer. (D)

Front 19

The U.S. Preventive Services Task Force (USPSTF) ________ routine screening for pancreatic cancer in asymptomatic adults using abdominal palpation, ultrasonography, or serologic markers.

Back 19

The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for pancreatic cancer in asymptomatic adults using abdominal palpation, ultrasonography, or serologic markers. (D)

Front 20

The U.S. Preventive Services Task Force (USPSTF) _____ routine screening for prostate cancer using prostate specific antigen (PSA) testing or digital rectal examination (DRE).

Back 20

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend for or against routine screening for prostate cancer using prostate specific antigen (PSA) testing or digital rectal examination (DRE).

Front 21

The U.S. Preventive Services Task Force (USPSTF) ______ routine screening for skin cancer using a total-body skin examination for the early detection of cutaneous melanoma, basal cell cancer, or squamous cell skin cancer.

Back 21

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend for or against routine screening for skin cancer using a total-body skin examination for the early detection of cutaneous melanoma, basal cell cancer, or squamous cell skin cancer.

Front 22

The U.S. Preventive Services Task Force ________ routine counseling by primary care clinicians to prevent skin cancer.

Back 22

The U.S. Preventive Services Task Force concludes that the evidence is insufficient to recommend for or against routine counseling by primary care clinicians to prevent skin cancer.

Front 23

The U.S. Preventive Services Task Force (USPSTF) ________ routine screening for testicular cancer in asymptomatic adolescent and adult males.

Back 23

The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for testicular cancer in asymptomatic adolescent and adult males. (D)

Front 24

The USPSTF _______ that clinicians screen all adults for tobacco use and provide tobacco cessation interventions for those who use tobacco products.

Back 24

The USPSTF strongly recommends that clinicians screen all adults for tobacco use and provide tobacco cessation interventions for those who use tobacco products. (A)

Front 25

The USPSTF _______ that clinicians screen all pregnant women for tobacco use and provide augmented pregnancy-tailored counseling to those who smoke.

Back 25

The USPSTF strongly recommends that clinicians screen all pregnant women for tobacco use and provide augmented pregnancy-tailored counseling to those who smoke. (A)

Front 26

The USPSTF ________ routine screening for tobacco use or interventions to prevent and treat tobacco use and dependence among children or adolescents.

Back 26

The USPSTF concludes that the evidence is insufficient to recommend for or against routine screening for tobacco use or interventions to prevent and treat tobacco use and dependence among children or adolescents.

Front 27

The U.S. Preventive Services Task Force (USPSTF) _______ the use of supplements of vitamins A, C, or E; multivitamins with folic acid; or antioxidant combinations for the prevention of cancer or cardiovascular disease.

Back 27

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend for or against the use of supplements of vitamins A, C, or E; multivitamins with folic acid; or antioxidant combinations for the prevention of cancer or cardiovascular disease.

Front 28

The USPSTF _________ the use of beta-carotene supplements, either alone or in combination, for the prevention of cancer or cardiovascular disease.

Back 28

The USPSTF recommends against the use of beta-carotene supplements, either alone or in combination, for the prevention of cancer or cardiovascular disease. (D)